# Predictive Biomarkers for Early Diagnosis of Pancreatic Ductal Adenocarcinoma (PDAC)

> **NCT07709052** · — · NOT_YET_RECRUITING · sponsor: **Azienda Ospedaliera Specializzata in Gastroenterologia Saverio de Bellis** · enrollment: 180 (estimated)

## Conditions studied

- Pancreatic Ductal Adenocarcinoma (PDAC)
- Intraductal Papillary Mucinous Neoplasm of Pancreas
- Pancreatic Intraepithelial Neoplasia

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT07709052
- **Lead sponsor:** Azienda Ospedaliera Specializzata in Gastroenterologia Saverio de Bellis
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-09-01
- **Primary completion:** 2027-09-01
- **Final completion:** 2028-09-01
- **Target enrollment:** 180 (ESTIMATED)
- **Last updated:** 2026-07-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07709052

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07709052, "Predictive Biomarkers for Early Diagnosis of Pancreatic Ductal Adenocarcinoma (PDAC)". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07709052. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*